Differential expression of vascular endothelial growth factor165b in transitional cell carcinoma of the bladder

Urologic Oncology: Seminars and Original Investigations

Volumn 25, Issue 4, 2007, Pages 317-321

  Das, Kakoli ^a   Zhao, Yi ^a   Sugiono, Marto ^a   Lau, Weber ^a   Tan, Puay Hoon ^a   Cheng, Christopher ^a  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

Author keywords

Angiogenesis; Bladder cancer; Gene expression; Transitional cell carcinoma of bladder; Vascular endothelial growth factor; Vascular endothelial growth factor165b

Indexed keywords

MESSENGER RNA; VASCULOTROPIN; VASCULOTROPIN 165;

ADULT; AGED; ARTICLE; BLADDER CANCER; BLADDER CARCINOMA; BLADDER TUMOR; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STATISTICAL SIGNIFICANCE; TRANSITIONAL CELL CARCINOMA; UPREGULATION;

ADULT; AGED; AGED, 80 AND OVER; BLOTTING, WESTERN; CARCINOMA, TRANSITIONAL CELL; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; PROTEIN ISOFORMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RISK FACTORS; RNA, MESSENGER; URINARY BLADDER NEOPLASMS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 34447100544     PISSN: 10781439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.urolonc.2007.01.015     Document Type: Article

References (21)

1. Seow A., Koh W.P., Chia K.S., et al. Cancer incidence in Singapore 1968-2002. Singapore Cancer Registry Report No. 6 (2004), Health Promotion Board, Singapore 132-133
2. Liotta L.A., Steeg P.S., and Stetler-Stevenson W.G. Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation. Cell 64 (1991) 327-336
3. Dickenson A.J., Fox S.B., Persad R.A., et al. Quantification of angiogenesis as an independent predictor of prognosis in invasive bladder carcinomas. Br J Urol 74 (1994) 762-766
4. Chaudhary R., Bromley M., Clarke N.W., et al. Prognostic relevance of micro-vessel density in cancer of the urinary bladder. Anticancer Res 19 (1999) 3479-3484
5. Carmeliet P., and Jain R.K. Angiogenesis in cancer and other diseases. Nature 407 (2000) 249-257
6. Brown L.F., Berse B., Jackman R.W., et al. Increased expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in kidney and bladder carcinomas. Am J Pathol 143 (1993) 1255-1262
7. Chabannes E., Bernardini S., Wallerand H., et al. Angiogenesis in bladder: Prognosis indicator and therapeutic target. Prog Urol 11 (2001) 417-427
8. O'Brien T., Cranston D., Fuggle S., et al. Different angiogenic pathways characterize superficial and invasive bladder cancer. Cancer Res 55 (1995) 510-513
9. Crew J.P., O'Brien T., Bradburn M., et al. Vascular endothelial growth factor is a predictor of relapse and stage progression in superficial bladder cancer. Cancer Res 57 (1997) 5281-5285
10. Fidler I.J., Naito S., and Pathak S. Orthotopic implantation is essential for the selection, growth and metastasis of human renal cell cancer in nude mice. Cancer Metastasis Rev 9 (1990) 149-165
11. 165b, an inhibitory splice variant of vascular endothelial growth factor, is down-regulated in renal cell carcinoma. Cancer Res 62 (2002) 4123-4131
12. 165b) mRNA and protein. Am J Physiol Renal Physiol 286 (2004) F767-F773
13. 165b, an inhibitory vascular endothelial growth factor splice variant: Mechanism of action, in vivo effect on angiogenesis and endogenous protein expression. Cancer Res 64 (2004) 7822-7835
14. th ed. (1997), Wiley-Liss, New York (NY) 170-173
15. Grunstein J., Masbad J.J., Hickey R., et al. Isoforms of vascular endothelial growth factor act in coordinate fashion to recruit and expand tumor vasculature. Mol Cell Biol 20 (2000) 7282-7291
16. Neufeld G., Cohen T., Gengrinovitch S., et al. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J 13 (1999) 9-22
17. Veikkola T., and Alitalo K. VEGFs, receptors and angiogenesis. Semin Cancer Biol 9 (1999) 211-220
18. Izawa J.I., and Dinney P.N.C. The role of angiogenesis in prostate and other urologic cancers: A review. CMAJ 164 (2001) 662-670
19. Vaerman J.L., Saussoy P., and Ingargiola I. Evaluation of real-time PCR data. J Biol Regul Homeost Agents 18 (2004) 212-214
20. Hanahan D., Christofori G., Naik P., et al. Transgenic mouse models of tumour angiogenesis: The angiogenic switch, its molecular controls, and prospects for preclinical therapeutic models. Eur J Cancer 32A (1996) 2386-2393
21. Kumar R., and Fidler I.J. Angiogenic molecules and cancer metastasis. Am J Pathol 143 (1993) 401-409